Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies

This publication has 48 references indexed in Scilit:

• Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, Pharmacokinetic and Scintigraphy study in mice model
  European Journal of Pharmaceutical Sciences, 2013
• Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: Effect of Vitamin E TPGS and nanocrystal particle size on oral absorption
  European Journal of Pharmaceutical Sciences, 2012
• Physicochemical and physiological considerations for efficient nose-to-brain targeting
  Expert Opinion on Drug Delivery, 2011
• Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth
  International Journal of Pharmaceutics, 2011
• Life-Threatening Clozapine-Induced Gastrointestinal Hypomotility
  The Journal of Clinical Psychiatry, 2008
• Permeation Studies and Histological Examination of Sheep Nasal Mucosa Following Administration of Different Nasal Formulations with or without Absorption Enhancers
  Drug Delivery, 2008
• Clozapine-Induced Agranulocytosis After 11 Years of Treatment
  American Journal of Psychiatry, 2005
• Biotransformation of Post-Clozapine Antipsychotics
  Clinical Pharmacokinetics, 2000
• Pharmacokinetics of Clozapine and Risperidone
  Journal of Clinical Psychopharmacology, 1996
• Clinical profile of clozapine: Adverse reactions and agranulocytosis
  Psychiatric Quarterly, 1992